in the reconstruction of what newron is carrying out for rett, the latest related release is missing in which FDA requests a meeting with the company to raise some doubts about the results of the experimentation provided necessary for the advancement of the drug. the newrn market does not seem to have positively interpreted this request from the FDA.
FDA trial Trofinetide/Lavender, page-23
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.93 |
Change
0.580(4.04%) |
Mkt cap ! $1.894B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $14.98 | $14.35 | $2.646M | 178.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 458 | $14.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.94 | 491 | 6 |
View Market Depth
| Last trade - 12.11pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |